JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
AAR Corp
AIR
$4.12B
| $7.89M | ﹤0.01% |
128,676
+87,939
| +216% | +$5.63M |
2013 Q2
46 quarters
|
|
2852
PUT
Cboe Global Markets
CBOE
$28.3B
| $7.86M | ﹤0.01% |
+40,200
| New | +$8.28M |
2024 Q4
0 quarters
|
|
2853
Stagwell
STGW
$2.04B
| $7.85M | ﹤0.01% |
1,193,355
+1,154,458
| +2,968% | +$8.23M |
2021 Q2
14 quarters
|
|
2854
CrossAmerica Partners
CAPL
$831M
| $7.84M | ﹤0.01% |
356,298
-4,933
| -1% | -$104K |
2022 Q3
9 quarters
|
|
|
MTTR
2855
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $7.83M | ﹤0.01% |
1,651,815
-315,400
| -16% | -$1.5M |
2021 Q3
13 quarters
|
|
2856
SITE Centers
SITC
$179M
| $7.83M | ﹤0.01% |
511,844
-2,149,289
| -81% | -$34.7M |
2013 Q2
46 quarters
|
|
2857
America Movil
AMX
$63.6B
| $7.82M | ﹤0.01% |
546,552
-294,783
| -35% | -$4.56M |
2013 Q2
46 quarters
|
|
2858
PUT
Sony
SONY
$139B
| $7.82M | ﹤0.01% |
369,500
+60,000
| +19% | +$1.17M |
2023 Q2
6 quarters
|
|
|
2859
CALL
Cboe Global Markets
CBOE
$28.3B
| $7.82M | ﹤0.01% |
+40,000
| New | +$8.24M |
2024 Q4
0 quarters
|
|
2860
PUT
Norfolk Southern
NSC
$71.3B
| $7.82M | ﹤0.01% |
33,300
+17,000
| +104% | +$4.32M |
2021 Q1
15 quarters
|
|
2861
CALL
Skyworks Solutions
SWKS
$12.8B
| $7.81M | ﹤0.01% |
88,100
| – | – |
2021 Q3
13 quarters
|
|
2862
Privia Health
PRVA
$2.59B
| $7.8M | ﹤0.01% |
398,738
+210,354
| +112% | +$4.17M |
2021 Q2
14 quarters
|
|
|
TGNA
2863
DELISTED
TEGNA Inc
TGNA
| $7.78M | ﹤0.01% |
425,565
+140,987
| +50% | +$2.47M |
2013 Q2
46 quarters
|
|
2864
CALL
Neurocrine Biosciences
NBIX
$14.6B
| $7.78M | ﹤0.01% |
57,000
+22,000
| +63% | +$2.72M |
2024 Q2
2 quarters
|
|
|
2865
PUT
Neurocrine Biosciences
NBIX
$14.6B
| $7.78M | ﹤0.01% |
57,000
+27,000
| +90% | +$3.34M |
2024 Q2
2 quarters
|
|
2866
Melco Resorts & Entertainment
MLCO
$1.59B
| $7.77M | ﹤0.01% |
1,342,132
+1,241,986
| +1,240% | +$8.37M |
2013 Q2
46 quarters
|
|
2867
US Physical Therapy
USPH
$1.25B
| $7.76M | ﹤0.01% |
87,501
+18,484
| +27% | +$1.65M |
2015 Q4
36 quarters
|
|
|
CHCT
2868
Community Healthcare Trust
CHCT
$390M
| $7.76M | ﹤0.01% |
403,945
+79,116
| +24% | +$1.43M |
2016 Q1
35 quarters
|
|
2869
Annexon
ANNX
$794M
| $7.75M | ﹤0.01% |
1,511,517
-194,665
| -11% | -$1.2M |
2020 Q3
17 quarters
|
|
2870
Huntsman Corp
HUN
$1.5B
| $7.75M | ﹤0.01% |
430,046
+192,738
| +81% | +$4.01M |
2013 Q2
46 quarters
|
|
2871
PUT
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$126M
| $7.75M | ﹤0.01% |
+169,200
| New | +$8.18M |
2024 Q4
0 quarters
|
|
2872
JPMorgan Active Bond ETF
JBND
$8.6B
| $7.75M | ﹤0.01% |
148,288
+148,287
| +14,828,700% | +$7.87M |
2024 Q3
1 quarter
|
|
2873
CALL
Carvana
CVNA
$45.9B
| $7.75M | ﹤0.01% |
190,500
+13,000
| +7% | +$584K |
2019 Q1
23 quarters
|
|
2874
CALL
Robinhood
HOOD
$101B
| $7.74M | ﹤0.01% |
207,800
+54,100
| +35% | +$1.75M |
2023 Q2
6 quarters
|
|
2875
CALL
Rio Tinto
RIO
$153B
| $7.74M | ﹤0.01% |
131,600
| – | – |
2023 Q2
6 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.